prophylaxis and treatment of infections caused by Erythromycin-sensitive
organisms. Erythromycin has been shown to have in-vitro activity against the following
micro-organisms: Gram positive cocci: Staphylococci and Streptococci.
influenzae, L-forms, Neisseria, Mycoplasma pneumoniae, Legionella pneumophila,
Branhamella catarrhalis, Bordetella pertussis Corynebacterium diphtheriae (as
an adjunct to antitoxin), Treponema pallidum, Chlamydia trachomatis, Ureaplasma
urealytica, Clostridia, Campylobacter.
respiratory tract infections: Tonsillitis, peritonsillar abscess, pharyngitis,
laryngitis, sinusitis, secondary infections in influenza and common colds.
respiratory tract infections: Tracheitis, acute and chronic bronchitis,
pneumonia (lobar pneumonia, bronchopneumonia, primary atypical pneumonia),
bronchiectasis, Legionnaire's disease.
infections: Otitis media and otitis externa, mastoiditis.
Oral/dental infections: Gingivitis, Vincent's angina.
and soft tissue infections: Boils and carbuncles, paronychia, abscesses, ustular
acne, impetigo, cellulitis, erysipelas.
Gastro-intestinal infections: cholecystitis, staphylococcal enterocolitis.
Prophylaxis: pre- and post- operative trauma, burns, rheumatic fever.
infections: osteomyelitis, urethritis, gonorrhoea, syphilis, lymphogranuloma
venereum, diphtheria, prostatitis, scarlet fever.
If you are a distributor, please inquire with us about product registration, importing and/or marketing our products in your country or region.
If you are a consumer, don't hesitate to contact us about more information for this product.
Product Categories : Finished Pharmaceutical Products > Antibiotic & Antimicrobial